BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21849505)

  • 21. Characterization of the deubiquitinating activity of USP19 and its role in endoplasmic reticulum-associated degradation.
    Lee JG; Kim W; Gygi S; Ye Y
    J Biol Chem; 2014 Feb; 289(6):3510-7. PubMed ID: 24356957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha.
    Furusu A; Nakayama K; Xu Q; Konta T; Kitamura M
    J Cell Physiol; 2007 Mar; 210(3):703-10. PubMed ID: 17133355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitor of apoptosis proteins as E3 ligases for ubiquitin and NEDD8.
    Kamada S
    Biomol Concepts; 2013 Apr; 4(2):161-71. PubMed ID: 25436573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.
    Li X; Yang Y; Ashwell JD
    Nature; 2002 Mar; 416(6878):345-7. PubMed ID: 11907583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
    Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
    Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1.
    Xu L; Zhu J; Hu X; Zhu H; Kim HT; LaBaer J; Goldberg A; Yuan J
    Mol Cell; 2007 Dec; 28(5):914-22. PubMed ID: 18082613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IAP family of cell death and signaling regulators.
    Silke J; Vucic D
    Methods Enzymol; 2014; 545():35-65. PubMed ID: 25065885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1.
    Lu Y; Adegoke OA; Nepveu A; Nakayama KI; Bedard N; Cheng D; Peng J; Wing SS
    Mol Cell Biol; 2009 Jan; 29(2):547-58. PubMed ID: 19015242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitor of apoptosis proteins as novel targets in inflammatory processes.
    Mayer BA; Rehberg M; Erhardt A; Wolf A; Reichel CA; Kracht M; Krombach F; Tiegs G; Zahler S; Vollmar AM; Fürst R
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2240-50. PubMed ID: 21817100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients.
    Ferreira CG; van der Valk P; Span SW; Jonker JM; Postmus PE; Kruyt FA; Giaccone G
    Ann Oncol; 2001 Jun; 12(6):799-805. PubMed ID: 11484955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression, regulation, and function of inhibitor of apoptosis family genes in rat mesangial cells.
    Furusu A; Nakayama K; Xu Q; Konta T; Sugiyama H; Kitamura M
    Kidney Int; 2001 Aug; 60(2):579-86. PubMed ID: 11473640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the membrane-bound Nrf1 transcription factor by USP19, a ubiquitin-specific protease C-terminally anchored in the endoplasmic reticulum.
    Hu S; Xiang Y; Qiu L; Wang M; Zhang Y
    Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119299. PubMed ID: 35613680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Domain interactions reveal auto-inhibition of the deubiquitinating enzyme USP19 and its activation by HSP90 in the modulation of huntingtin aggregation.
    Xue W; Zhang SX; He WT; Hong JY; Jiang LL; Hu HY
    Biochem J; 2020 Nov; 477(21):4295-4312. PubMed ID: 33094816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid-dependent expression of IAP participates in the protection against TNF-mediated cytotoxicity in MCF7 cells.
    Mitre-Aguilar IB; Barrios-Garcia T; Ruiz-Lopez VM; Cabrera-Quintero AJ; Mejia-Dominguez NR; Ventura-Gallegos JL; Moreno-Mitre D; Aranda-Gutierrez A; Mejia-Rangel J; Escalona-Guzman AR; Chavarri-Guerra Y; Leon-Del-Rio A; Zentella-Dehesa A
    BMC Cancer; 2019 Apr; 19(1):356. PubMed ID: 30987626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of apoptosis catch ubiquitin.
    Rajalingam K; Dikic I
    Biochem J; 2009 Jan; 417(1):e1-3. PubMed ID: 19061481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways.
    Varfolomeev E; Vucic D
    Cell Cycle; 2008 Jun; 7(11):1511-21. PubMed ID: 18469528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases.
    Broemer M; Tenev T; Rigbolt KT; Hempel S; Blagoev B; Silke J; Ditzel M; Meier P
    Mol Cell; 2010 Dec; 40(5):810-22. PubMed ID: 21145488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
    Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
    Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ubiquitin ligase ability of IAPs regulates apoptosis.
    Ni T; Li W; Zou F
    IUBMB Life; 2005 Dec; 57(12):779-85. PubMed ID: 16393780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
    Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
    Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.